|
US2021106498A1
|
|
Plastic Jacket for Vial Labeling Systems
|
|
US2021062150A1
|
|
Methods of preparing t cells for t cell therapy
|
|
US2021061881A1
|
|
Chimeric cytokine receptors comprising tgf beta binding domains
|
|
WO2020252381A2
|
|
Anti-talen antibodies and uses thereof
|
|
US2020339944A1
|
|
Methods of manufacturing allogeneic car t cells
|
|
WO2020219848A1
|
|
Rituximab-resistant chimeric antigen receptors and uses thereof
|
|
WO2020214937A1
|
|
Antibodies against 4g7-derived chimeric antigen receptors
|
|
WO2020191378A1
|
|
METHODS FOR ENHANCING TCRαβ+ CELL DEPLETION EFFICIENCY
|
|
WO2020180664A1
|
|
Chimeric cytokine receptors bearing a pd-1 ectodomain
|
|
US2020291090A1
|
|
Constitutively active chimeric cytokine receptors
|
|
WO2020180591A1
|
|
Dll3 targeting chimeric antigen receptors and binding agents
|
|
US2020261503A1
|
|
Chimeric antigen receptors targeting b-cell maturation antigen and methods of use thereof
|
|
CN111819192A
|
|
Inducible chimeric cytokine receptors
|
|
US2019127721A1
|
|
Modified caspase-9 polypeptides and methods of use thereof
|
|
CN111886015A
|
|
Methods and compositions for administration of allogeneic chimeric antigen receptor T cells
|
|
KR20190141206A
|
|
Improved T Cell Compositions and Methods
|
